These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 5736504)

  • 21. Vascular symptomatic relief during administration of ethylchlorophenoxyisobutyrate (clofibrate).
    Albert M; Stansell MJ
    Metabolism; 1969 Aug; 18(8):635-45. PubMed ID: 4895062
    [No Abstract]   [Full Text] [Related]  

  • 22. [How sure is the combined lipid lowering?].
    Schäfer J
    MMW Fortschr Med; 2005 Jan; 147(1-2):56. PubMed ID: 15704576
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dyslipoproteinemia of diabetes: fibrates or statins?].
    Moulin P
    Diabetes Metab; 1999 Sep; 25(3):270-4. PubMed ID: 10499198
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experience with an antilipemic agent, ethylchlorophenoxyisobutyrate].
    Noleto PA; de Bulhões F; Tuma M
    Rev Bras Med; 1969 Oct; 26(10):602-5. PubMed ID: 5404870
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacologic treatment of dyslipidemia.
    McCormick JJ; Deeg MA
    Am J Nurs; 2000 Feb; 100(2):55-60. PubMed ID: 10683645
    [No Abstract]   [Full Text] [Related]  

  • 26. [Drug therapy of dyslipidemias].
    Fonda M; Cattin L; Guarnieri G
    Recenti Prog Med; 2000; 91(7-8):375-8. PubMed ID: 10932924
    [No Abstract]   [Full Text] [Related]  

  • 27. Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate.
    Högberg T; Bondesson G; Stjernström NE
    Acta Pharm Suec; 1977; 14(2):149-60. PubMed ID: 906832
    [No Abstract]   [Full Text] [Related]  

  • 28. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia].
    Martínez-Castelao A
    Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262
    [No Abstract]   [Full Text] [Related]  

  • 29. [Critical evaluation of indications for lipid reduction. Cholesterol value updated--risk counts (interview by Dr. Kirsten Westphal)].
    Motz W
    MMW Fortschr Med; 2003 Oct; 145(41):48. PubMed ID: 14655487
    [No Abstract]   [Full Text] [Related]  

  • 30. [Treatment of diabetes insipidus with clofibrate].
    Annee Endocrinol; 1971; 23():101-3. PubMed ID: 5562226
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical and biological study of a new vascular protective agent and hypolipemic agent, pyridoxine para-chloro-phénoxy-isobutyrate. (Claresan)].
    Fourrier A; Mouton Y
    Lille Med; 1974 Apr; 19(4 Suppl 11):532-7. PubMed ID: 4612283
    [No Abstract]   [Full Text] [Related]  

  • 32. Clofibrate.
    Br Med J; 1970 Sep; 3(5723):632. PubMed ID: 5470094
    [No Abstract]   [Full Text] [Related]  

  • 33. Clofibrate and dextrothyroxine in coronary heart diseases. A clinical and biochemical study.
    Bhatia ML; Setty KR; Roy SB
    J Assoc Physicians India; 1971 Feb; 19(2):123-9. PubMed ID: 4934418
    [No Abstract]   [Full Text] [Related]  

  • 34. Drugs for hyperlipedemia.
    DiPalma JR
    RN; 1974 Mar; 37(3):55-62. PubMed ID: 4494775
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of dyslipidemias and its benefits].
    Taskinen MR
    Duodecim; 1999; 115(10):1138-44. PubMed ID: 11877853
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of arteriosclerosis by Atromid].
    Ayad H
    Rev Med Moyen Orient; 1967; 24(6):504-11. PubMed ID: 5264185
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical and biological aspects of hyperlipemia].
    Turcanu V; Bartl F; Fiat F
    Med Interna (Bucur); 1970 Apr; 22(4):489-93. PubMed ID: 4246119
    [No Abstract]   [Full Text] [Related]  

  • 38. [AVERT study (Atorvastatin Versus Revascularization Treatment). Clinical advantage of aggressive lipid lowering].
    Z Kardiol; 1999 Mar; 88(3 Suppl):1-4. PubMed ID: 10330699
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical study of the effect of ethyl-alpha-p-chlorophenoxybutyrate (clofibrate) in the venous retinal thrombosis].
    Cioli S; Nizzola GM
    Ann Ottalmol Clin Ocul; 1970 Sep; 96(9):477-82. PubMed ID: 5519038
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic study of clofibrate during pituitrin-sensitive diabetes insipidus in children].
    de Gennes JL; Desbois JC; Marie J
    Ann Pediatr (Paris); 1970 Nov; 17(11):754-9. PubMed ID: 5484620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.